Celldex (CLDX) Tops Q2 EPS by 5c
Tweet
Share
E-mail
Get Alerts CLDX Hot Sheet
Join SI Premium – FREE
Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.54), $0.05 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $2.49 million versus the consensus estimate of $854.29 thousand.
For earnings history and earnings-related data on Celldex (CLDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Starts SpaceX (SPCX) at Outperform
- SpaceX: New Street Research sees 22% upside from proposed IPO price
- Morgan Stanley Upgrades Towa Pharmaceutical Co Ltd (4553:JP) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
